In the nearly one month since federal health officials signed off on "mixing and matching" the Covid-19 booster shot, one group has overwhelmingly opted to switch its vaccine compared to others. One expert says the switch away from Johnson & Johnson appears to be largely driven by data that shows mRNA boosters from Pfizer and Moderna produce a stronger antibody response.
No comments:
Post a Comment